TY - JOUR
T1 - Parkinson’s disease laterality
T2 - a 11C-PE2I PET imaging study
AU - Roussakis, Andreas Antonios
AU - Zeng, Zhou
AU - Lao-Kaim, Nicholas P.
AU - Martin-Bastida, Antonio
AU - Piccini, Paola
AU - Barker, Roger A.
AU - Farrell, Krista
AU - Guzman, Natalie Valle
AU - He, Xiaoling
AU - Lazic, Stanley E.
AU - Moore, Sarah
AU - Morris, Robert
AU - Tyers, Pamela
AU - Wijeyekoon, Ruwani
AU - Daft, Danielle
AU - Hewitt, Sam
AU - Dayal, Biswas
AU - Foltynie, Thomas
AU - Kefalopoulou, Zenobia
AU - Mahlknecht, Philipp
AU - Bjartmarz, Hjalmar
AU - Björklund, Anders
AU - Lindvall, Olle
AU - Nelander-Wahlestedt, Jenny
AU - Parmar, Malin
AU - Paul, Gesine
AU - Widner, Hakan
AU - Church, Alistair
AU - Dunnett, Stephen
AU - Peall, Kathryn
AU - Rosser, Anne
AU - Gurruchaga, Jean Marc
AU - Palfi, Stéphane
AU - Piroth, Tobias
AU - Winkler, Christian
AU - TRANSEURO consortium
PY - 2020/1
Y1 - 2020/1
N2 - Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriate clinical assessments. 11C-PE2I non-displaceable binding potential (BPND) was calculated bilaterally for the striatum at baseline and follow-up to estimate the in vivo density of striatal dopamine transporters (DAT). Changes in striatal 11C-PE2I BPND over time were more prominent in the ipsilateral as compared to contralateral side. Changes in MDS-UPDRS-III (motor component of the Movement Disorders Society Unified PD Rating Scale) were not different between the clinically most and least affected body sides. Our data support that the asymmetry in striatal dopaminergic degeneration becomes less prominent in moderate-stage PD. In contrast, during the above period, the asymmetry of motor symptoms was maintained between the clinically most and least affected body sides.
AB - Asymmetry of striatal dopaminergic deficits and motor symptoms is a typical characteristic of idiopathic Parkinson’s disease (PD). This study aims to characterise the trend of asymmetry in moderate-stage PD. We performed a 19-month longitudinal study in 27 patients with PET-CT imaging and appropriate clinical assessments. 11C-PE2I non-displaceable binding potential (BPND) was calculated bilaterally for the striatum at baseline and follow-up to estimate the in vivo density of striatal dopamine transporters (DAT). Changes in striatal 11C-PE2I BPND over time were more prominent in the ipsilateral as compared to contralateral side. Changes in MDS-UPDRS-III (motor component of the Movement Disorders Society Unified PD Rating Scale) were not different between the clinically most and least affected body sides. Our data support that the asymmetry in striatal dopaminergic degeneration becomes less prominent in moderate-stage PD. In contrast, during the above period, the asymmetry of motor symptoms was maintained between the clinically most and least affected body sides.
KW - Asymmetry
KW - Dopamine transporter
KW - Parkinson’s disease
KW - Positron emission tomography
KW - Striatum
UR - http://www.scopus.com/inward/record.url?scp=85090092361&partnerID=8YFLogxK
U2 - 10.1007/s00415-020-10204-y
DO - 10.1007/s00415-020-10204-y
M3 - Article
C2 - 32880071
AN - SCOPUS:85090092361
SN - 0340-5354
JO - Journal of Neurology
JF - Journal of Neurology
ER -